US 11174301
Peptide compound
granted A61KA61K38/00A61K47/60
Quick answer
US patent 11174301 (Peptide compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61K47/60, A61P, A61P1/08